Skip to main content
HealthReportedMediumDeveloping
4.6

Once-daily pill plus chemo shows promise in advanced pancreatic cancer trial

A phase trial of a once-daily oral drug combined with chemotherapy reportedly eliminated disease in roughly 1 in 12 patients with advanced pancreatic cancer, per RTÉ. The result is early-stage and unverified; durability and survival benefit remain unquantified. If confirmed, it would mark a meaningful advance in a malignancy with historically poor outcomes.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

RTÉ1 day agoengCredibility 23%View source

Score Breakdown

Mosaic Score4.6
Model confidence0.3
Significance0.5
Source credibility0.2
Source

Related signals

8 found